Aktuellt
SENASTE
Redeye initiates coverage of Surgical Science, a serial acquirer sporting healthy organic growth prospects. Considering the company’s robust expected organic sales growth and margin expansion in the coming years, we believe today’s share price offers an attractive entry point for long-term-oriented investors.
LÄS MER
